Tilray Brands, Inc. (TLRY), Investor Memo – Growth Outlook, Risks & Long-Term Value

*Disclosure: This memo is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities.

Investment Thesis

Tilray Brands has transitioned from a Canadian cannabis cultivator into a diversified, consumer-oriented platform spanning cannabis, beverages, and international markets. This evolution improves revenue durability and margin potential while embedding significant regulatory optionality. Long-term equity value is most sensitive to U.S. federal cannabis reform, execution across acquired assets, and sustained margin discipline.

Core Growth Engines

Beverages & Consumer Brands

Tilray’s beverage strategy is central to its long-term value creation. Cannabis-infused beverages and traditional beverage brands offer higher margins, repeat-purchase economics, and scalable distribution. This segment also provides strategic positioning for eventual U.S. market expansion.

Canadian Cannabis Leadership

Canada remains Tilray’s operational base, where it holds leading positions across multiple product categories. While growth is modest, scale supports cost efficiency, innovation, and stable cash generation.

International Cannabis Expansion

International medical cannabis continues to represent a high-optionality growth vector. Select markets offer favorable regulatory structures, geographic diversification, and potential margin upside over time.

Brewery & Non-Cannabis Assets

Tilray’s brewery and beverage assets diversify cash flows and reduce reliance on cannabis pricing cycles. These businesses act as financial ballast while reinforcing distribution and branding capabilities.

Key Risks

• U.S. Federal Policy Uncertainty: Delayed reform limits capital access, banking, and tax normalization.
• Execution & Integration: Margin expansion depends on disciplined integration of acquisitions.
• Pricing Pressure: Competition and illicit markets constrain pricing power.
• Capital Allocation: Dilution or poorly timed M&A could impair shareholder returns.

Long-Term Value Drivers

• Regulatory-driven multiple expansion in the U.S.
• Margin expansion from beverages and branded consumer products.
• International scale and operating leverage.
• Improved cost of capital as policy risk declines.

Bull / Base / Bear Valuation Snapshot (Illustrative)

Bull Case – Regulatory Re-Rating

U.S. federal reform advances, beverages scale successfully, and international cannabis grows at double-digit rates. EBITDA margins exceed 20% and valuation multiples expand materially.

Outcome: Multi-bagger upside driven by policy change and margin expansion.

Base Case – Gradual Progress

U.S. reform remains incremental, Canada stabilizes, and beverages grow steadily. Management maintains cost discipline and avoids major dilution.

Outcome: Moderate appreciation supported by improving fundamentals.

Bear Case – Policy Stagnation

Federal reform stalls, pricing pressure intensifies, and execution challenges persist. Margins remain constrained and capital access stays limited.

Outcome: Meaningful downside, with shares trading as a stressed operator.

Bottom Line: Tilray represents a high-optionality, policy-levered investment with a more resilient business model than early-generation cannabis peers. Upside is driven by regulatory reform and margin execution; downside is mitigated by diversification.

*Disclosure: This memo is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities.